派林生物: 关于部分募集资金专户完成销户的公告

Group 1 - The company has raised a total of RMB 1,577,739,984.00 through a private placement of 48,004,800 shares at a price of RMB 33.33 per share, with a net amount of RMB 1,575,241,979.20 after deducting issuance costs [1][2] - The company has established a special account for the management and use of the raised funds, ensuring compliance with relevant laws and regulations [2][3] - The company has signed multiple regulatory agreements with various banks and its sponsor to ensure proper oversight of the raised funds [3] Group 2 - The company has completed the investment projects funded by the raised capital, including the "New and Relocated Plasma Collection Station Project" and "Information Technology Construction Project" [4] - A total of RMB 4.0496 million from the special account has been transferred to other fundraising accounts, and the company has initiated the closure of certain fundraising accounts [4][5] - The closure of the fundraising accounts has been communicated to the sponsor and relevant parties, and the associated regulatory agreements have been terminated [4][5]